Generic Name: glucagon
Brand Name: TBC
Manufacturer: Eli Lilly Canada Inc.
Indications: Severe hypoglycemic reactions
Manufacturer Requested Reimbursement Criteria1:
For the treatment of severe hypoglycemic reactions which may occur in the management of insulin treated adult and pediatric patients with diabetes mellitus, when impaired consciousness precludes oral carbohydrates.
Submission Type: New
Project Status: Pending
Call For Patient Input: June 25, 2019
Patient Input Closed: August 15, 2019
Anticipated Date: July 24, 2019
Fee Schedule: Pending
- The requested reimbursement criteria are provided by the applicant and do not necessarily reflect the views of CADTH. Reimbursement criteria from CADTH will be documented in the final recommendation, if applicable.